Wall Street analysts expect HCP, Inc. (NYSE:HCP) to report $0.43 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for HCP’s earnings, with the lowest EPS estimate coming in at $0.40 and the highest estimate coming in at $0.45. HCP reported earnings of $0.48 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 10.4%. The firm is scheduled to announce its next quarterly earnings results before the market opens on Wednesday, October 31st.
On average, analysts expect that HCP will report full year earnings of $1.82 per share for the current financial year, with EPS estimates ranging from $1.79 to $1.84. For the next financial year, analysts anticipate that the company will post earnings of $1.79 per share, with EPS estimates ranging from $1.65 to $1.84. Zacks’ earnings per share averages are a mean average based on a survey of research firms that follow HCP.
HCP (NYSE:HCP) last released its quarterly earnings results on Thursday, August 2nd. The real estate investment trust reported $0.19 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.46 by ($0.27). HCP had a return on equity of 1.12% and a net margin of 3.39%. The firm had revenue of $469.60 million for the quarter, compared to analysts’ expectations of $463.94 million. During the same period last year, the firm earned $0.48 EPS. The business’s quarterly revenue was up 2.3% on a year-over-year basis.
HCP stock traded down $0.12 during midday trading on Friday, hitting $25.20. 2,294,837 shares of the stock were exchanged, compared to its average volume of 3,495,368. HCP has a 1 year low of $21.48 and a 1 year high of $27.62. The company has a market capitalization of $12.37 billion, a price-to-earnings ratio of 12.92, a price-to-earnings-growth ratio of 6.61 and a beta of 0.28. The company has a debt-to-equity ratio of 1.37, a current ratio of 0.51 and a quick ratio of 0.51.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Stephens Inc. AR increased its position in shares of HCP by 5.1% in the 2nd quarter. Stephens Inc. AR now owns 40,944 shares of the real estate investment trust’s stock worth $1,057,000 after purchasing an additional 1,993 shares during the last quarter. Advisor Partners LLC increased its position in shares of HCP by 20.7% in the 2nd quarter. Advisor Partners LLC now owns 11,864 shares of the real estate investment trust’s stock worth $306,000 after purchasing an additional 2,038 shares during the last quarter. Amalgamated Bank increased its position in shares of HCP by 3.6% in the 2nd quarter. Amalgamated Bank now owns 60,479 shares of the real estate investment trust’s stock worth $1,562,000 after purchasing an additional 2,084 shares during the last quarter. Spearhead Capital Advisors LLC increased its position in shares of HCP by 1.8% in the 2nd quarter. Spearhead Capital Advisors LLC now owns 137,553 shares of the real estate investment trust’s stock worth $3,552,000 after purchasing an additional 2,398 shares during the last quarter. Finally, First Midwest Bank Trust Division increased its position in shares of HCP by 9.3% in the 2nd quarter. First Midwest Bank Trust Division now owns 28,695 shares of the real estate investment trust’s stock worth $741,000 after purchasing an additional 2,433 shares during the last quarter. 88.30% of the stock is owned by institutional investors.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Story: What is the NASDAQ?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.